Wed.Jul 05, 2023

article thumbnail

STAT+: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic

STAT

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.

Diabetes 263
article thumbnail

A BMS exec’s journey around the world in 90 days

PharmaVoice

As BMS grapples with upcoming patent cliffs, Emma Charles, the new SVP of intercontinental markets, is focused on expanding its footprint.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The 27 best books and podcasts on health and science to check out this summer

STAT

With summer in full swing, it’s a great time to tuck into a new book or podcast. Whether you’re looking for gripping personal stories or fascinating histories of deadly pathogens, our annual list of health, medicine, and science titles has something for everyone. Read on for recommendations from the likes of Deputy CDC Director Nirav Shah, Boston Public Health Commission Executive Director Bisola Ojikutu, and Gavi CEO Seth Berkley.

246
246
article thumbnail

Women’s healthcare investments are hot. So where are the new menopause drugs?

PharmaVoice

NK3 receptor antagonists offer a new option, but experts say more are needed.

148
148
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Black Americans living in disadvantaged neighborhoods age faster than white peers, study finds

STAT

Black Americans who live in neighborhoods with lower levels of income and education may age faster than their white neighbors, according to a new study. This can be true even when an individual Black person has a higher income or education level — underscoring the extent to which a person’s surroundings can impact their health. The study , published Wednesday in PLOS ONE, builds on an emerging body of research that links faster biological aging, measured by a process called DNA met

227
227
article thumbnail

With new data, J&J steps forward in growing race for oral autoimmune drugs

BioPharma Dive

Phase 2 results show a pill the company is developing is competitive with other oral medicines in testing against psoriasis, among them the TYK2 inhibitors that have drawn significant industry interest.

109
109

More Trending

article thumbnail

Health Equity in Pharma: Communities Most Impacted by Racial Bias

PharmExec

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

105
105
article thumbnail

First pediatric study to test neutralizing antibodies against HIV shows promise

STAT

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of the trial, documented in a study published Wednesday in Science Translational Medicine, show that broadly neutralizing antibodies can boost the protective effects of antiretroviral drugs.

article thumbnail

Women in Science: How Charco Neurotech's Lucy Jung is 'restoring joy' for Parkinson's patients

Outsourcing Pharma

Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a non-invasive wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement. We spoke to her about her background, how she got involved in the Parkinson's space and her fascination for problem-solving.

105
105
article thumbnail

STAT+: Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch

STAT

Good morning, everyone, and nice to see you again after an extended holiday break, at least for many on this side of the pond. We hope the last few days have been refreshing and invigorating, no matter what you were up to. As for us, we are easing back in to the usual routine as we prepare for online calls and deadlines. Some things never change. So to get started, we are brewing a cup of stimulation, which we understand continues to have some worthwhile attributes.

Diabetes 176
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Probe into UKHSA finds weak financial controls and 'alarming' lack of pandemic planning

The Pharmacist

The UK Health Security Agency (UKHSA) was set up with financial controls ‘so poor’ that it cannot establish whether its transactions were in line with its purpose as laid out by parliament. This meant that the UKHSA’s £3.3bn worth of inventory transferred from NHS Test and Trace could not be verified by proper financial records. […] The post Probe into UKHSA finds weak financial controls and 'alarming' lack of pandemic planning appeared first on The Pharmacist.

98
article thumbnail

Opinion: Listen: Is the medical system ready for Alzheimer’s drugs that work?

STAT

An effective treatment for Alzheimer’s disease has long been a holy grail in the pharmaceutical industry. In early June, some hope appeared when the FDA agreed that the anti-amyloid antibody lecanemab (to be sold by Eisai as Leqembi) outperformed placebo in trials. It is expected to receive full approval by July 6. But this may not necessarily be purely good news.

166
166
article thumbnail

More detail on proposed pharmacist apprenticeships needed

The Pharmacist

Pharmacist degree apprenticeships are being considered as part of NHS England’s plan to increase the workforce. In the NHS Long Term Workforce Plan, published last week (30 June), NHS England (NHSE) said there was potential for pharmacy technicians to undertake expanded training via apprenticeships, and that consideration was being given to the potential of […] The post More detail on proposed pharmacist apprenticeships needed appeared first on The Pharmacist.

article thumbnail

Sarepta sells FDA fast pass earned from Duchenne gene therapy approval

BioPharma Dive

The deal enables Sarepta to quickly cash in on the clearance of Elevidys, with $102 million in new funds to help bankroll its drug research.

104
104
article thumbnail

Incyte’s non-segmental vitiligo treatment approved in UK

Pharmaceutical Technology

Following FDA approival and CE marking for Incyte’s JAK-inhibiting cream Opzelura (ruxolitinib), the MHRA has followed suit in the UK.

105
105
article thumbnail

FDA Approves BioMarin’s Roctavian, the First Gene Therapy for Treating Severe Hemophilia A

PharmaTech

FDA has approved Roctavian (valoctocogene roxaparvovec-rvox), a gene therapy from BioMarin Pharmaceutical for treating severe hemophilia A in adults.

98
article thumbnail

Amneal Parkinson’s drug IPX203 needs to compete with novel subcutaneous levodopa delivery systems post FDA CRL:  GlobalData

Express Pharma

Following the news that Amneal Pharmaceuticals received a complete response letter (CRL) from the FDA, concerning its new drug application for IPX203 (carbidopa/levodopa) as a treatment for Parkinson’s disease (PD); Christie Wong, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “Although levodopa has been the gold standard for patients with PD for over 50 years, occurrences of peak-dose dyskinesia and off-episodes are common motor complications that are ca

87
article thumbnail

Vertex’s Orkambi receives EC approval

Pharma Times

Orkambi is an oral treatment for very young children that combines both lumacaftor and ivacaftor - News - PharmaTimes

102
102
article thumbnail

Make Summertime Growth Time

Integra X Files

Pharmacy managers often find themselves caught in a frustrating dilemma: balancing the need to serve existing customers while also seeking new ones to expand their business. Your competitors continue to multiply, and you begin to see one or more customers get picked up by a competitor you never heard of. At the beginning of summer, our minds usually drift towards thoughts of vacation, gardening, long weekends, and sand between our toes.

article thumbnail

Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago

Express Pharma

Venus Remedies has received marketing approvals from Oman, Malaysia, Bosnia and Trinidad and Tobago for key chemotherapy drugs. With this, the company has secured 503 marketing approvals for its oncology products across 75 countries. While Venus Remedies has secured marketing approval for pemetrexed from Malaysia, it has done product registration for docetaxel in Oman, gemcitabine in Bosnia and carboplatin, bortezomib and docetaxel in Trinidid and Tobago.

article thumbnail

MHRA reveals new corporate plan to expedite drug regulatory journeys in UK

Pharmaceutical Technology

The corporate strategy aims to introduce new legislation for faster regulations, new international collaborations, and digitisation.

98
article thumbnail

BDR Pharma launches Nilotinib to treat PH+ leukemia

Express Pharma

BDR Pharma announced the launch of Nilotinib to treat a rare subtype of acute lymphoblastic leukemia. PH+ Leukemia, encompassing Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML) are infrequent and complex types of cancer that affect both children and adults. While this Philadelphia chromosome is rare in paediatric ALL, it is much more common in adult ALL.

82
article thumbnail

How to Find Your First Pharmacy Technician Position

The Script

Are you searching for your first pharmacy technician position? Rx relief breaks down our top advice on finding your first role.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing. The long-awaited PDA TR 43 report provides an approach to a quality decision-making process and represents best practices for the identification and classification of visual nonconformities for (empty) glass containers as pharmaceutical product packaging.

article thumbnail

Artificial cells demonstrate that "life finds a way"

World Pharma News

"Listen, if there's one thing the history of evolution has taught us is that life will not be contained. Life breaks free. It expands to new territories, and it crashes through barriers painfully, maybe even dangerously, but. life finds a way," said Ian Malcolm, Jeff Goldblum's character in Jurassic Park, the 1993 science fiction film about a park with living dinosaurs.

78
article thumbnail

European Commission extends approval of cystic fibrosis medicine

European Pharmaceutical Review

European Commission (EC) has granted approval for the label extension of cystic fibrosis medicine ORKAMBI ® (lumacaftor/ivacaftor) for children aged one to <2 years old. The oral treatment is indicated to treat these individuals with two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene for the first time.

article thumbnail

NHS chief admits ‘no specific’ funding for retention in workforce plan

The Pharmacist

There are no ‘specific costs’ associated with retention elements of the long-term workforce plan, NHS England’s chief executive has admitted. Speaking at a Public Accounts Committee (PAC) session on urgent and emergency care, Amanda Pritchard confirmed that none of the £2.4bn investment in the plan will go towards workforce retention. As well as pledging to increase […] The post NHS chief admits ‘no specific’ funding for retention in workforce plan appeared first on The Pharmacist.

70
article thumbnail

Positive efficacy data for Sensorian’s candidate

Pharma Times

SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation - News - PharmaTimes

70
article thumbnail

Why the ‘80/20 Rule’ does NOT rule the specialty pharmaceutical industry

pharmaphorum

Why the ‘80/20 Rule’ does NOT rule the specialty pharmaceutical industry Mike.

92
article thumbnail

‘Mixed’ results seed doubt about AstraZeneca, Daiichi’s next cancer drug

BioPharma Dive

The medicine delayed disease progression compared to chemotherapy in a closely watched lung cancer trial. But analysts questioned its effect size and safety, and AstraZeneca shares fell more than 8%.

article thumbnail

Episode 832: Savings realized by the redistribution of short-dated emergency medications

Pharmacy Joe

In this episode, I’ll discuss a cost-avoidance study of a redistribution process to reduce waste of emergency medications in drug boxes. Episode 832: Savings realized by the redistribution of short-dated emergency medications Subscribe on iTunes , Android , or Stitcher Placing emergency medications throughout the hospital in drug boxes is essential to ensure their availability when emergencies arise.

article thumbnail

Collaboration with industry will help NHS face next 75 years, says ABPI

pharmaphorum

Collaboration with industry will help NHS face next 75 years, says ABPI Mike.

91
article thumbnail

Moderna, chasing GSK and Pfizer, brings RSV vaccine to regulators

BioPharma Dive

The vaccine has a chance to become Moderna’s second approved product and could help offset declining sales for its COVID-19 shot.

article thumbnail

Positive new phase 3 MRI data from UPLIZNA trial for NMOSD

pharmaphorum

Positive new phase 3 MRI data from UPLIZNA trial for NMOSD Nicole.

90
article thumbnail

Cytovation appoints Olav Hellebø to board of directors

Pharmafile

Cytovation ASA, a clinical stage immune-oncology company with a focus on targeted tumour membrane immunotherapies, has announced that it has appointed Olav Hellebø to its board of directors. Hellebø brings with him extensive leadership experience from US- and Europe-based pharmaceutical and biotechnology companies, having previously acted as chief executive officer at ReNeuron and Clavis Pharma. […] The post Cytovation appoints Olav Hellebø to board of directors appeared first on Pharmafil